Reverse transcriptase mutant for hot start and application thereof
By localizing and modifying the temperature-sensitive sites of reverse transcriptase, low-temperature inactivated and high-temperature activity reverse transcriptase mutants are formed, which solves the problem of mismatch between traditional reverse transcriptase and DNA polymerase activity and improves PCR amplification Increased efficiency.
Patent Information
- Application Number
- CN202411346370.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-26
- Publication Date
- 2024-12-06
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Traditional reverse transcriptase activity does not match DNA polymerase under high temperature conditions, resulting in many steps and long use of PCR amplification process and low efficiency.
Through calculation and simulation, the three-dimensional structure of reverse transcriptase was analyzed, the temperature-sensitive amino acid sites were located, and the cleavage and mutagenesis were carried out to form mutant nucleotide sequences, which were integrated into the original reverse transcriptase, and the low-temperature inactivation and high-temperature activity were screened out. The reverse transcriptase mutant was combined with DNA polymerase for PCR amplification.
Reduce PCR amplification steps, improve amplification efficiency, ensure that reverse transcriptase works in concert with DNA polymerase under high temperature conditions, and improve PCR reaction efficiency.
Smart Images

Figure CN119082076A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of genetic engineering, in particular to a hot-start reverse transcriptase mutant and an application thereof. Background Art
[0002] Reverse transcriptase is a key enzyme for synthesizing cDNA from RNA templates. The RNA sample and appropriate primers are mixed, and reverse transcriptase uses the RNA sample and primers to synthesize a DNA chain complementary to the RNA sample, which is then amplified by PCR to obtain enough target DNA. Among them, the hot-start reverse transcriptase mutant refers to a reverse transcriptase that has undergone specific mutation design and optimization and is used for the hot-start method. The hot-start method is a technique used in molecular biology that increases the specificity of the reaction and reduces nonspecific amplification by activating the activity of the enzyme at a specific temperature. It is widely used in molecular biology research.
[0003] Conventional reverse transcriptase may induce non-specific cDNA synthesis at room temperature, resulting in errors in experimental results. For example, CN117778349A involves a hot-start reverse transcriptase mutant and its application. The amino acid sequence that affects the hot-start stability of the reverse transcriptase is determined based on bioinformatics analysis, and the amino acid sequence is mutated and the codon is optimized to obtain a polynucleotide sequence. The polynucleotide sequence is integrated into a synthetic fragment of the hot-start reverse transcriptase mutant. After designing RT primers, the synthetic fragment is PCR amplified using the RT primers, and the PCR product and the linearized vector are seamlessly cloned. After verification by colony PCR, plasmid extraction is performed, and the obtained plasmid is transformed into prokaryotic cells. A single bacterium is picked for expansion and culture, broken, separated and purified to obtain a hot-start reverse transcriptase mutant. The hot-start reverse transcriptase mutant has higher efficiency and stability in various applications, and is helpful for application in biomolecular reactions such as polymerase chain reaction amplification, gene cloning, and sequencing reactions under high temperature conditions.
[0004] During PCR amplification of DNA, reverse transcriptase and DNA polymerase work together. The problem is that DNA polymerase has higher activity only at higher temperatures, while the reverse transcriptase mutant prepared by the above patent has higher activity only at 35-70°C. The optimal working temperature ranges of the two do not match. During PCR amplification, the reverse transcriptase can only be reversed first, and then the DNA polymerase amplification process can be performed. This results in more steps in the PCR amplification process, and it takes a long time, and the PCR amplification efficiency is low.
[0005] In order to ensure that reverse transcriptase still has high activity at a higher temperature so as to cooperate with DNA polymerase to improve PCR amplification efficiency, a method for preparing a hot start reverse transcriptase mutant and its application are proposed. Summary of the invention
[0006] The object of the present invention is to provide a hot-start reverse transcriptase mutant and its application to solve the problems raised in the above background technology.
[0007] To achieve the above object, the present invention provides a method for hot-starting a reverse transcriptase mutant, comprising the following steps:
[0008] S1. Analyze the three-dimensional structure of reverse transcriptase through computational simulation, locate the temperature-sensitive amino acid sites and cut out the nucleotide sequence materials;
[0009] S2, mutagenizing the nucleotide sequence material to obtain a variant nucleotide sequence, and then integrating the variant nucleotide sequence into the original reverse transcriptase sequence to obtain a variant reverse transcriptase material;
[0010] S3, after cloning the mutant reverse transcriptase material, screening the high and low temperature activities, obtaining the reverse transcriptase mutant material that meets the requirements of low temperature inactivation and high temperature activation;
[0011] S4. Introducing the reverse transcriptase mutant material into the cell expansion culture, and obtaining a high-purity reverse transcriptase mutant through crushing, separation, and chromatography purification.
[0012] As a further improvement of the present technical solution, in S1, the temperature-sensitive amino acid sites in the reverse transcriptase nucleotide sequence are first classified and marked, and then the marked amino acid sites are trimmed by nuclease, and the phosphodiester bonds in the nucleotide chain are hydrolyzed to obtain the nucleotide sequence material of the marked sites, and the nucleotide sequence of the original reverse transcriptase is preserved.
[0013] As a further improvement of the present technical solution, the endonuclease is a restriction endonuclease.
[0014] As a further improvement of the present technical solution, in S2, the nucleotide sequence material is subjected to site-directed mutagenesis and random induced mutation by chemical mutagens to obtain a variant nucleotide sequence, and then the variant nucleotide sequence is introduced into the nucleotide sequence of the original reverse transcriptase corresponding to the cutting site to reintegrate and generate the variant reverse transcriptase material.
[0015] As a further improvement of the technical solution, the mutant nucleotide sequence and the original reverse transcriptase nucleotide sequence are integrated by E. coli DNA ligase and T4 DNA ligase.
[0016] As a further improvement of the present technical solution, in S3, a plurality of variant reverse transcriptase materials are first labeled and corresponding primers are generated, and then the variant reverse transcriptase materials are amplified by seamless cloning technology, and then high and low temperature activity tests are performed to screen out reverse transcriptase mutant materials that are completely inactivated at low temperatures and recover activity at high temperatures.
[0017] As a further improvement of the technical solution, in S3, the high and low temperature activity screening specifically includes the following steps:
[0018] Low temperature activity test: Mix the mutant reverse transcriptase material with the RNA sample template and primers with non-specific background, react at low temperature, and measure the enzyme activity;
[0019] High temperature activity test: Test the activity of the enzyme at different temperatures above 45°C, and determine the optimal working temperature range of the reverse transcription reaction through experiments.
[0020] As a further improvement of the present technical solution, in S4, after the reverse transcriptase mutant material is introduced into Escherichia coli cells for expansion culture, the Escherichia coli cells expressing the reverse transcriptase mutant material are lysed by ultrasonic fragmentation or high-pressure homogenization, and then separated and purified by chromatography to obtain a high-purity reverse transcriptase mutant.
[0021] Correspondingly, the application of the hot start reverse transcriptase mutant in polymerase chain reaction amplification under high temperature conditions.
[0022] Compared with the prior art, the present invention has the following beneficial effects:
[0023] The hot-start reverse transcriptase mutant and its application are as follows: by locating key amino acid sites that are sensitive to temperature and may affect the enzyme activity state, and cutting to obtain nucleotide sequence materials, a large number of variant nucleotide sequences are obtained by site-directed mutagenesis and chemical mutagen-induced mutation of the nucleotide sequence, and the variant reverse transcriptase materials are reintegrated. The reverse transcriptase mutants that are inactivated at low temperatures but have higher activity at higher temperatures are screened out through high and low temperature activity tests, so that the reverse transcriptase mutants can be easily cooperated with DNA polymerase to simultaneously carry out the PCR amplification process, reduce the steps and time of the amplification process, and thus improve the PCR amplification efficiency. BRIEF DESCRIPTION OF THE DRAWINGS
[0024] Figure 1 is a flow chart of the present invention;
[0025] Figure 2 It is a comparison chart of PCR amplification efficiency of the present invention. DETAILED DESCRIPTION
[0026] The following will be combined with the accompanying drawings in the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0027] Example 1
[0028] See also Figure 1 As shown, the purpose of this embodiment is to provide a method for hot starting a reverse transcriptase mutant, comprising the following steps:
[0029] S1. The three-dimensional structure of the reverse transcriptase is analyzed by computational simulation using protein structure simulation software, and the key amino acid sites in the reverse transcriptase nucleotide sequence that are sensitive to temperature and may affect the enzyme activity state are located and classified. The marked amino acid sites are then cut by endonucleases, and the phosphodiester bonds in the nucleotide chains are hydrolyzed to obtain the nucleotide sequence materials of the marked sites, and the nucleotide sequence of the original reverse transcriptase is saved.
[0030] The endonuclease is a restriction endonuclease, and the fast endonuclease EcoRV is preferably used in the present invention, which can recognize and attach to a specific nucleotide sequence and cut the phosphodiester bond between two ribonucleotides at a specific position in each chain;
[0031] S2, performing site-directed mutagenesis on the nucleotide sequence material and randomly inducing mutagenesis by chemical mutagens to obtain a large number of variant nucleotide sequences, then introducing the variant nucleotide sequences into the nucleotide sequence of the original reverse transcriptase in correspondence with the cutting sites, integrating the variant nucleotide sequences with the nucleotide sequence of the original reverse transcriptase by E. coli DNA ligase and T4 DNA ligase, connecting the nucleotide sequence fragments by the cooperation of E. coli DNA ligase and T4 DNA ligase, ensuring that the variant nucleotide sequences can be integrated with the nucleotide sequence of the original reverse transcriptase, and generating variant reverse transcriptase materials;
[0032] The present invention obtains a large number of samples through site-directed mutagenesis and random induced mutagenesis, wherein the site-directed mutagenesis is site-directed mutagenesis mediated by polymerase chain reaction (PCR), and amino acid substitution is performed on the target site. For example, hydrophobic amino acids can be replaced with polar amino acids, so that the enzyme folds in a different way at low temperatures and loses its activity; random induced mutagenesis includes physical mutagen-induced mutagenesis and chemical mutagen-induced mutagenesis. Since physical mutagens use ultraviolet rays, X-rays, gamma rays, fast neutrons, lasers, microwaves and ion beams to directly or indirectly affect the structure of DNA and cause mutations, which may cause deletion and damage to nucleotide sequences, the present invention uses chemical mutagens, alkylating agents or base analogs to randomly induce point mutations in nucleotide sequences, rather than large fragment deletions, thereby achieving large-scale creation of mutants;
[0033] S3. First, multiple mutant reverse transcriptase materials are marked and corresponding primers are generated using SnapGene software. Then, the mutant reverse transcriptase materials are amplified using seamless cloning technology. Then, reverse transcriptase mutant materials that are completely inactivated at low temperatures and recover activity at high temperatures are screened out through high and low temperature activity tests.
[0034] Among them, the high and low temperature activity screening specifically includes the following steps:
[0035] Low temperature activity test: Mix the mutant reverse transcriptase material with the non-specific background RNA sample template and primers, react at low temperature (such as 25°C or 37°C), and measure the enzyme activity;
[0036] High temperature activity test: Test the activity of the enzyme at different temperatures above 45°C, and determine the optimal working temperature range of the reverse transcription reaction through experiments;
[0037] S4. After the reverse transcriptase mutant material is introduced into Escherichia coli cells for amplification, the Escherichia coli cells expressing the reverse transcriptase mutant material are lysed by ultrasonic disruption or high-pressure homogenization, and then separated and purified by chromatography to obtain a high-purity reverse transcriptase mutant.
[0038] Example 2
[0039] The purpose of this embodiment is to provide an application of a hot-start reverse transcriptase mutant in polymerase chain reaction amplification under high temperature conditions. Taking the 2×Power hot-start Taq premix (dye) (item number A036-10) of Beijing Kangrun Chengye Biotechnology Co., Ltd. as an example, the product is a premixed ready-to-use 2-fold concentration PCR solution containing components such as optimized concentrations of HotStart Power Taq DNA polymerase, dNTPs, Mg2+, reaction buffer and stabilizer. The activation of HotStart Power Taq DNA polymerase requires incubation at 95°C for 10 minutes, and it is inactive at temperatures below 75°C.
[0040] According to the method provided in Example 1, a reverse transcriptase mutant having an optimal operating temperature range for reverse transcription reaction and matching the operating temperature range of HotStartPower Taq DNA polymerase was prepared.
[0041] First, according to steps S1 and S2 of the method, the amino acid sites on the reverse transcriptase that may affect the high and low temperature states of the reverse transcriptase are trimmed, and the nucleotide sequence obtained by trimming is induced to mutate, and the mutated variant nucleotide sequence is reintegrated back into the original nucleotide sequence to produce a variant reverse transcriptase material.
[0042] Secondly, in step S3 of the method, after the variant reverse transcriptase material is cloned, a low-temperature activity test is performed. The variant reverse transcriptase material is mixed with the RNA sample template and primers of the non-specific background, and the variant reverse transcriptase material that has a reverse transcription reaction at a low temperature (such as 25°C or 37°C) is first removed. The remaining variant reverse transcriptase materials are tested for high-temperature activity to screen out the variant reverse transcriptase materials that can perform a reverse transcription reaction at a temperature above 75°C.
[0043] Then, according to step S4 of the method, the screened variant reverse transcriptase material (when there is more than one variant reverse transcriptase material that can perform reverse transcription reaction at above 75°C, the one with higher working temperature and higher reverse transcription reaction rate is selected) is introduced into Escherichia coli cells for expanded culture, the Escherichia coli cells are lysed, and then separated and purified by chromatography to obtain a high-purity reverse transcriptase mutant.
[0044] Example 3
[0045] In order to verify that the reverse transcriptase mutant obtained in Example 2 can be combined with 2×Power Hot Start Taq premix to improve the PCR amplification efficiency, RNA samples with non-specific background were extracted from samples (such as tissues, cells, viruses), and the 2×Power Hot Start Taq premix was incubated at 95°C for 10 minutes to activate the HotStart Power Taq DNA polymerase, and then the RNA samples were divided into the following three groups:
[0046] The first group used common reverse transcriptase such as M-MLV reverse transcriptase to generate complementary DNA using RNA sample as template, and then amplified DNA using 2×Power hot start Taq premix at a temperature not lower than 75°C;
[0047] The second group directly mixed the common reverse transcriptase, 2×Power Hot Start Taq premix and RNA sample at a temperature not lower than 75°C;
[0048] The third group directly mixed the reverse transcriptase mutant obtained in Example 2, 2×Power hot start Taq premix and RNA sample at a temperature not lower than 75°C.
[0049] The above three groups were tested for PCR amplification efficiency, and the test results were as follows: Figure 2 As shown, Figure 2 The first group is A, the second group is B, and the third group is C. Figure 2 It can be seen that when the common reverse transcriptase, 2×Power Hot Start Taq premix and RNA sample are directly mixed under a temperature condition of not less than 75°C, the reverse transcription process of the common reverse transcriptase is affected by the high temperature, resulting in the PCR amplification efficiency of the second group being lower than that of the first group, while the PCR amplification efficiency of the third group is higher than that of the first group. This proves that the reverse transcriptase mutant obtained in Example 2 can be combined with the 2×Power Hot Start Taq premix to improve the PCR amplification efficiency.
[0050] The above shows and describes the basic principles, main features and advantages of the present invention. Those skilled in the art should understand that the present invention is not limited by the above embodiments. The above embodiments and descriptions are only preferred examples of the present invention and are not intended to limit the present invention. Without departing from the spirit and scope of the present invention, the present invention may have various changes and improvements, which fall within the scope of the present invention. The scope of protection of the present invention is defined by the attached claims and their equivalents.
Claims
1. A reverse transcriptase mutant for hot start, characterized in that: The hot start reverse transcriptase mutant is prepared by the following steps: S1. Analyze the three-dimensional structure of reverse transcriptase through computational simulation, locate the temperature-sensitive amino acid sites and cut out the nucleotide sequence materials; S2, mutagenizing the nucleotide sequence material to obtain a variant nucleotide sequence, and then integrating the variant nucleotide sequence into the original reverse transcriptase sequence to obtain a variant reverse transcriptase material; S3, after cloning the mutant reverse transcriptase material, screening the high and low temperature activities, obtaining the reverse transcriptase mutant material that meets the requirements of low temperature inactivation and high temperature activation; S4. Introducing the reverse transcriptase mutant material into the cell expansion culture, and obtaining a high-purity reverse transcriptase mutant through crushing, separation, and chromatography purification.
2. The hot-start reverse transcriptase mutant according to claim 1, characterized in that: In S1, the temperature-sensitive amino acid sites in the reverse transcriptase nucleotide sequence are first classified and marked, and then the marked amino acid sites are trimmed by nuclease, and the phosphodiester bonds in the nucleotide chain are hydrolyzed to obtain the nucleotide sequence material of the marked sites, and the nucleotide sequence of the original reverse transcriptase is preserved.
3. The hot-start reverse transcriptase mutant according to claim 2, characterized in that: The endonuclease is a restriction endonuclease.
4. The hot-start reverse transcriptase mutant according to claim 1, characterized in that: In S2, the nucleotide sequence material is subjected to site-directed mutagenesis and random induced mutagenesis by chemical mutagens to obtain a variant nucleotide sequence, and then the variant nucleotide sequence is introduced into the nucleotide sequence of the original reverse transcriptase corresponding to the cutting site to reintegrate and generate the variant reverse transcriptase material.
5. The hot-start reverse transcriptase mutant according to claim 4, characterized in that: The mutant nucleotide sequence was integrated with the original reverse transcriptase nucleotide sequence by E. coli DNA ligase and T4 DNA ligase.
6. The hot-start reverse transcriptase mutant according to claim 1, characterized in that: In S3, a plurality of mutant reverse transcriptase materials are first labeled and corresponding primers are generated, and then the mutant reverse transcriptase materials are amplified by seamless cloning technology, and then the reverse transcriptase mutant materials that are completely inactivated at low temperature and recover activity at high temperature are screened out by high and low temperature activity tests.
7. The hot-start reverse transcriptase mutant according to claim 1, characterized in that: In S3, the high and low temperature activity screening specifically includes the following steps: Low temperature activity test: Mix the mutant reverse transcriptase material with the RNA sample template and primers with non-specific background, react at low temperature, and measure the enzyme activity; High temperature activity test: Test the activity of the enzyme at different temperatures above 45°C, and determine the optimal working temperature range of the reverse transcription reaction through experiments.
8. The hot-start reverse transcriptase mutant according to claim 1, characterized in that: In S4, after the reverse transcriptase mutant material is introduced into Escherichia coli cells for amplification, the Escherichia coli cells expressing the reverse transcriptase mutant material are lysed by ultrasonic disruption or high-pressure homogenization, and then separated and purified by chromatography to obtain a high-purity reverse transcriptase mutant.
9. Use of the hot-start reverse transcriptase mutant according to any one of claims 1 to 8 in polymerase chain reaction amplification under high temperature conditions.
Citation Information
Patent Citations
A method of preparing high-performance M-MLV reverse transcriptase
CN106906237A
M-MLV reverse transcriptase mutant and application thereof
CN113355303A
Reverse transcriptase mutant for hot start and application thereof
CN117778349A
ECB deacylase mutants
US6361988B1
Thermostable reverse transcriptase and use thereof
WO2024092768A1
